• Press Release

Mount Sinai Showcases Breast Cancer Research at the 2025 San Antonio Breast Cancer Symposium

New York skyscraper seen from a park
  • San Antonio, TX
  • (December 08, 2025)

Researchers and clinicians from the Icahn School of Medicine at Mount Sinai will present new discoveries in breast cancer biology, treatment, and real-world patient outcomes at the 2025 San Antonio Breast Cancer Symposium (SABCS), Tuesday-Friday, December 9-12, in San Antonio, Texas.  

SABCS is one of the world’s leading conferences dedicated to breast cancer research and clinical advances, bringing together global experts to highlight the newest insights that may shape the future of care. Mount Sinai’s contributions this year span artificial intelligence, triple-negative breast cancer, geriatric oncology, and novel therapeutic approaches. 

Below is a selection of Mount Sinai’s presentations at SABCS 2025: 

 

Oral Session:

Multimodal artificial intelligence (AI) models integrating image, clinical, and molecular data for predicting early and late breast cancer recurrence in TAILORx 
Joseph Sparano, MD 
Wednesday December 10, General Session 1, 9:30 am-noon CST 
https://sabcs.org/events/general-session-1/ 

  

Posters:

Abstract: 2137 
A novel therapeutic targeting triple negative breast cancer brain metastases 
Hanna Irie, MD, PhD  

Abstract: 811 
Tolerability of the KEYNOTE-522 regimen in a diverse real-world cohort of patients with early triple negative breast cancer (TNBC) 
Justine M. Anderson, MD (Clinical Fellow, Hematology and Medical Oncology); Rima Patel, MD, is senior author 

Abstract: 865  
Evaluating real world pathologic complete response (pCR) rates at an urban center following the KEYNOTE-522 regimen for early-stage TNBC 
Justine M. Anderson, MD (Clinical Fellow, Hematology and Medical Oncology); Rima Patel, MD, is senior author 

Abstract: 869 
Evaluating the tolerability of the combination of adjuvant pembrolizumab and capecitabine in a diverse real-world cohort of patients with early-stage TNBC 
Prathyusha Pandu, MD (Internal Medicine resident); Amy Tiersten, MD, is senior author 

Presentation: #PS4-07-26 
Safety and efficacy of neoadjuvant cyclophosphamide, methotrexate, fluorouracil (CMF) and pembrolizumab in older adults with early triple negative breast cancer (TNBC) 
Rima Patel, MD

Presentation: #PS5-09-21 
Feasibility of Clinical Nurse-Initiated Geriatric Assessments in Breast Medical Oncology Clinic: A Pilot Program 
Rima Patel, MD 

 

For a full list of presentations or to learn more about the 2025 San Antonio Breast Cancer Symposium, visit https://sabcs.org/. 

 

About the Icahn School of Medicine at Mount Sinai  

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the seven member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population.  

The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. Its Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 560 postdoctoral research fellows.  

Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges.  More than 4,500 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. 

-------------------------------------------------------  

* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.    

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2025-2026.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.

Related Articles
Building exterior
Building exterior
Myeloma
New York skyscrapers
New York skyscraper seen from a park
Researcher using microscope